The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Guideline of guidelines: non‐muscle‐invasive bladder cancer
Open accessAbstract
Non‐muscle‐invasive bladder cancer ( NMIBC ) represents the vast majority of bladder cancer diagnoses, but this definition represents a spectrum of disease with a variable clinical course, notable for significant risk of recurrence and potential for progression. Management involves risk‐adapted strategies of cystoscopic surveillance and intravesical therapy with the goal of bladder preservation when safe to do so. Multiple organizational guidelines exist to help practitioners manage this complicated disease process, but adherence to management principles among practising urologists is reportedly low. We review four major organizational guidelines on NMIBC : the American Urological Association ( AUA )/Society of Urologic Oncology ( SUO ), European Association of Urology ( EAU ), National Comprehensive Cancer Network ( NCCN ), and National Institute for Health and Care Excellence ( NICE ) guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.029 · Cited by 3,086
Sylvester, R. J., van der Meijden, A. P. M., Oosterlinck, W., Witjes, J. A., Bouffioux, C., Denis, L., Newling, D. W. W., & Kurth, K. (2006) · European Urology · doi:10.1016/j.eururo.2005.12.031 · Cited by 3,013
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E. M., Hernández, V., Kaasinen, E., Palou, J., Rouprêt, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2016.05.041 · Cited by 2,241
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Burger, M., Catto, J. W. F., Dalbagni, G., Grossman, H. B., Herr, H., Karakiewicz, P., Kassouf, W., Kiemeney, L. A., La Vecchia, C., Shariat, S., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.07.033 · Cited by 2,164
Self-citationHumphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M., & Reuter, V. E. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.028 · Cited by 1,916
SYLVESTER, R. J., van der MEIJDEN, A. P. M., & LAMM, D. L. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64273-5 · Cited by 1,312
WHO Classification of of Tumours of the Urinary System and Male Genital Organs
Ulbright, T. M., Amin, M. B., Balzer, B. W. R., Berney, D. M., Epstein, J., Guo, C. C., Idrees, M. T., Looijenga, L. H. J., Paner, G. P., Meyts, E. R., et al. (2016) · Cited by 915
SYLVESTER, R. J., OOSTERLINCK, W., & van der MEIJDEN, A. P. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000125486.92260.b2 · Cited by 743
Metadata
- Authors
- Woldu, S. L., Bagrodia, A., & Lotan, Y.
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2017-01-24
- Volume
- 119
- Issue
- 3
- Pages
- 371-380
- ISSN
- 1464-4096 (ISSN-L)
- 1464-410X
- OpenAlex
- W2570682666
- Cited by
- 272
- References
- 39
- FWCI
- 26.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guideline of guidelines: non‐muscle‐invasive bladder cancer. https://app.cochat.ai/papers/10.1111/bju.13760
- The paper
- Woldu, S. L., Bagrodia, A., & Lotan, Y. (2017). Guideline of guidelines: non‐muscle‐invasive bladder cancer. BJU International. https://doi.org/10.1111/bju.13760
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.